Adenosine triphosphate (ATP) is the universal energy currency of our cells. It is hydrolyzed to fuel energy-requiring biological processes and is continuously resynthesized by condensation of adenosine diphosphate (ADP) and inorganic phosphate (Pi). In humans, roughly our body weight of ATP has to be recycled every day ([@r1]). Most of this ATP is produced in mitochondria via oxidative phosphorylation (OXPHOS) in a process that couples the activity of the electron transport chain (ETC) to that of the ATP synthase. OXPHOS is carried out by five major protein complexes embedded in the inner mitochondrial membrane. Complexes I to IV form the ETC responsible for maintenance of the protonmotive force (PMF) that drives ATP synthesis by complex V, the F~1~F~o~-ATP synthase. Complexes I and II oxidize NADH and succinate, respectively, and pass their electrons via ubiquinone to complex III. Complex III relays the electrons via soluble cytochrome *c* to complex IV (cytochrome *c* oxidase, C*c*O), which reduces molecular oxygen to water.

Complexes I, III, and IV have evolved mechanisms to maximize the efficiency of capture into the PMF of the energy released by their redox reactions ([@r2], [@r3]). In mitochondrial C*c*O, the reduction of molecular oxygen to water with four electrons from intermembrane cytochrome *c* and four substrate protons from the matrix conserves part of the available redox energy in the PMF. However, in each full catalytic cycle, four additional protons are transferred across the inner mitochondrial membrane ([@r4]), roughly doubling the energy capture efficiency. Substrate and translocated protons must traverse the overall hydrophobic membrane protein along hydrophilic channels formed by appropriate amino acids and associated waters ([@r5], [@r6]), and three possible pathways for this have been identified within available atomic structures ([@r7], [@r8]): the D-, K-, and H-channels. To investigate their contribution to the coupling mechanism, a wide range of spectroscopic, electrometric, mutation and simulation studies have been performed on bacterial A1-type heme-copper oxidases (HCOs), which are closely related to mitochondrial C*c*Os ([@r9][@r10]--[@r11]) and have the same catalytic cycle and 1H^+^/e^−^ pumping stoichiometry. The most widely studied of these are the quinol oxidase, cytochrome *bo*~3~, from *Escherichia coli* and the *aa*~3~ C*c*Os from *Rhodobacter sphaeroides* and *Paracoccus denitrificans*.

A consensus has been reached on the essential contributions of the K- and D-channels to the oxygen reduction cycle and delivery of the substrate protons to the binuclear center (BNC) ([@r12][@r13][@r14]--[@r15]). In addition, it is generally acknowledged that translocated protons that are taken up from the negative aqueous (N) phase of the inner membrane are stored in a transient proton trap before they are expelled into the positive aqueous (P) phase ([@r16]). However, there is an ongoing dispute regarding the path into the trap for translocated protons. A diverse body of data on bacterial systems indicates that the D-channel provides a major section of that path ([@r12], [@r15]); however, structural studies and more limited biophysical data on mammalian (bovine) mitochondrial C*c*O suggest that the translocated protons instead travel into the trap via the H-channel ([@r17]).

Here we address this issue using yeast (*Saccharomyces cerevisiae*) mitochondrial C*c*O. This system has the crucial advantage of facile mtDNA mutagenesis technology that has enabled the mutation of residues of mtDNA-encoded subunit I (Cox1) located in the D-, K-, and H-channels. Mutations in the D- and H-channels were originally described by Meunier et al. ([@r19]), with sites chosen from a three-dimensional (3D) model of the yeast enzyme built by sequence homology onto the bovine enzyme crystal structure ([@r20]). The positions of all mutations used in the present study were recently confirmed in the atomic resolution structure of the yeast C*c*O ([@r18]) ([Fig. 1](#fig01){ref-type="fig"}). Here we show that effects of mutations in all three channels on catalytic turnover and coupled proton transfer closely mirror the effects of equivalent mutations in the closely related bacterial oxidases, supporting a common coupling mechanism in all members of the A1-type branch of HCOs independent of their bacterial or mitochondrial origin.

![The three possible proton-conducting channels of yeast C*c*O. The residues forming the H-, D-, and K-channels are colored in green, orange, and purple, respectively. D445E and E39Q, which are not located in the proton channels, are displayed in yellow. Atomic coordinates were taken from Protein Data Bank ID code 6HU9 ([@r18]).](pnas.2001572117fig01){#fig01}

Results {#s1}
=======

Mutations in the D- and the K-Channels Are Detrimental to Respiratory Growth, but Those in the H-Channel Are Not. {#s2}
-----------------------------------------------------------------------------------------------------------------

All yeast strains were derived from W303-1B (WT) which was modified to express C*c*O with a 6-histidine tag at the C terminus of its Cox13 subunit (6H-WT), as described by Meunier et al. ([@r19]). Subsequently, variants of 6H-WT were constructed harboring point mutations in the three putative proton pathways within Cox1: N99D, E243D, and I67N in the D-channel; Q411L, Q413L, S382A, S458A, S455A, and S52D in the H-channel; and T316K in the K-channel ([Fig. 1](#fig01){ref-type="fig"}). Two other mutant strains were also included in this study: D445E, previously identified by random mutagenesis to be respiratory-deficient ([@r21]), and E39Q, which contributes to the Na^+^/Ca^2+^-binding site near the top of the H-channel (both displayed in yellow in [Fig. 1](#fig01){ref-type="fig"}). All mutant strains presented here successfully assembled C*c*O ([*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2001572117/-/DCSupplemental)).

The effect of the mutations was first assessed on whole-cell doubling times when cultured in a medium with the respiratory substrate glycerol ([Fig. 2](#fig02){ref-type="fig"}). The doubling times of the six H-channel mutants were not significantly different from those of the WT or 6H-WT strain (mean, 3.6 ± 0.4 h for the 6H-WT strain). This contrasts with the D- and K-channel mutants, all of which showed longer doubling times, ranging from mild (N99D, 5.4 ± 0.9 h) to severe (I67N and T316K, 196.1 ± 78.4 and 40.5 ± 4.7 h, respectively) respiratory growth impairment. Mutant D445E (15.9 ± 1.8 h) showed a pronounced respiratory impairment, while E39Q grew with a doubling time similar to WT.

![Doubling times of yeast strains cultured in glycerol medium. The strains harbor mutations in the H- (green), D- (orange), or K-channel (purple), the three putative proton transfer pathways in Cox1, or mutations E39Q and D445E. Also included for comparison are the WT yeast strain and the WT with an additional 6-histidine tag at the C terminus of the nuclear encoded subunit Cox13 (6H-WT), both displayed in black.](pnas.2001572117fig02){#fig02}

Mutations in the D- and K-Channels, but Not Those in the H-Channel, Severely Affect Catalytic Turnover. {#s3}
-------------------------------------------------------------------------------------------------------

Yeast strains were grown aerobically on galactose and mitochondrial membrane fragments were prepared from cells harvested in log phase ([@r19]) ([*Materials and Methods*](#s10){ref-type="sec"}). Turnover numbers (TNs) for each C*c*O variant were determined from oxygen consumption rates at pH 6.6 in the presence of *N*,*N*,*N*′,*N*′-tetramethyl-p-phenylenediamine (TMPD), ascorbate, and cytochrome *c* ([Fig. 3](#fig03){ref-type="fig"} and [*SI Appendix*, Table S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2001572117/-/DCSupplemental)). All H-channel mutants and E39Q displayed a TN similar to that of WT (1175 ± 161 e⋅s^−1^). Significantly different TNs were measured for the three D-channel variants, with reduced rates for I67N and E243D (1% and 46% of the WT value, respectively) but an enhanced rate for N99D (151% of the WT value). The K-channel mutant T316K also had a low TN (15% of WT) as did the D445E mutant (44% of WT).

![TNs of C*c*O in mitochondrial membranes. TNs were measured from oxygen consumption rates at pH 6.6 in the presence of ascorbate, TMPD, and cytochrome *c* and are expressed as electrons per second (e.s^−1^) per C*c*O.](pnas.2001572117fig03){#fig03}

ADP/O Ratios: Theoretical Values. {#s4}
---------------------------------

ADP/O ratios (and hence H^+^/e^−^ ratios) were determined with ADP pulses given to intact isolated mitochondria respiring with a respiratory substrate for all variants except I67N, whose TN is too low to allow measurement. Several substrates were tested, including NADH, succinate, and ethanol ([*SI Appendix*, Table S2](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2001572117/-/DCSupplemental)), but the highest respiratory coupling ratios (RCRs; ratio of state 3/state 4 respiratory rates) ([@r22]), and therefore the most accurate H^+^/e^−^ ratios (see below), were obtained with α-ketoglutarate. This is because α-ketoglutarate is oxidized only by intact mitochondria ([@r23]) and because of the direct kinetic control exerted by the ADP/ATP ratio on α-ketoglutarate dehydrogenase ([@r24]).

α-Ketoglutarate is imported into mitochondria via a specific carrier that exchanges it for malate. Once inside the mitochondrion, α-ketoglutarate enters the Krebs cycle, where it is converted to succinyl CoA by α-ketoglutarate dehydrogenase, producing one equivalent of NADH. Succinyl CoA is transformed into succinate by succinyl thiokinase, producing one ATP equivalent. Succinate is then oxidized to fumarate by complex II, and fumarate is converted to malate, which is transported out of the mitochondrion in exchange for another α-ketoglutarate. In *S. cerevisiae* mitochondria, both succinate and NADH reduce ubiquinone with nonprotonmotive enzymes ([@r25]). For every two electrons from reduced ubiquinone passing through complexes III and IV to reduce 1/2 O~2~ to H~2~O, six protons are translocated across the membrane. Thus, since succinate and NADH together provide four electrons to the ETC, reducing O~2~ into 2 H~2~O, this results in the translocation of 12 H^+^ from the matrix to the intermembrane space (IMS) and the formation of one matrix-located ATP. As one H^+^ is used to export this substrate-level ATP out of the matrix, one α-ketoglutarate results in 11 H^+^ overall and one ATP translocated from the matrix to the IMS. The yeast *S. cerevisiae* F~1~F~o~-ATPase has 10 c-subunits ([@r26]), so 10 H^+^ are required to produce three molecules of matrix ATP, and three additional H^+^ are required to translocate them into the IMS, i.e., 13 H^+^ for three ATP~cytoplasmic~. Thus, when one α-ketoglutarate is oxidized to malate, two O (one O~2~) are reduced, and the total ATP produced outside the matrix is 1~substrate~ ~level-ATP~ + 11/(13/3)~OXPHOS-ATP~ = 3.54, giving an ADP/O ratio of 3.54/2 = 1.77 (of which 1.27 ATP arise from OXPHOS and 0.5 ATP arises from substrate-level phosphorylation). If the proton translocation activity of C*c*O becomes uncoupled from its oxygen-reducing cycle (i.e., oxygen reduction and proton uptake to form water occur but no additional protons are translocated), then the oxidation of α-ketoglutarate to malate results in only eight proton translocations (four from succinate and four from NADH), decreasing the ADP/O ratio to (1~substrate~ ~level-ATP~ + 7/(13/3)~OXPHOS-ATP~)/2 = 1.31, of which 0.81 ATP now arises from OXPHOS and 0.5 ATP is still produced from substrate-level phosphorylation.

Mutation in the Yeast Mitochondrial C*c*O D-Channel, but Not in the H- or K-Channel, Results in Loss of Coupled Proton Translocation. {#s5}
-------------------------------------------------------------------------------------------------------------------------------------

With α-ketoglutarate as a substrate, RCRs following small additions of ADP ranged from 1.6 to 2.4 in different preparations of intact mitochondria ([*SI Appendix*, Table S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2001572117/-/DCSupplemental)). ADP/O ratios were calculated from the additional oxygen consumption induced by ADP conversion to ATP under the assumption that 50% of state 4 oxygen consumption rate continues in state 3, as described in [*Materials and Methods*](#s10){ref-type="sec"}. In this case, the measured ADP/O ratio of 6H-WT mitochondria was 1.73 ± 0.15 ([Fig. 4 *A* and *B*](#fig04){ref-type="fig"}), which is close to the theoretical value of 1.77 for a fully coupled respiratory chain, giving an H^+^/e^−^ pumping stoichiometry of 0.9 ± 0.3 for C*c*O (see above). All H-channel mutants and K-channel mutant T316K displayed ADP/O ratios similar to that of the 6H-WT ([Fig. 4*B*](#fig04){ref-type="fig"}), as did E39Q and D445E, ruling out any essential involvement of these residues in proton translocation. In contrast, mutations in the D-channel gave significantly different ADP/O ratios. E243D displayed a higher value, at 2.18 ± 0.10 ([Fig. 4*B*](#fig04){ref-type="fig"}). The most reasonable explanation for this finding is that \<50% of the state 4 rate persists in state 3 in this mutant, with no change to the H^+^/e^−^ stoichiometry of C*c*O. However, mutant N99D displayed an ADP/O ratio of 1.39 ± 0.09 ([Fig. 4 *A* and *B*](#fig04){ref-type="fig"}), consistent with a loss of the coupled proton translocation associated with the C*c*O oxygen reduction cycle.

![ADP/O ratio measurements on preparations of intact mitochondria. (*A*) Oxygen consumption rates of intact yeast mitochondria respiring on α-ketoglutarate. (*B*) Calculated ADP/O ratios during state 3 respiration. Theoretical ADP/O values for respiration on α-ketoglutarate are 1.77 (± 10%; orange band) and 1.31 (± 10%; blue band) depending on whether the C*c*O additional proton translocation is fully coupled (H^+^/e^−^ ratio of 1.0 ± 0.4) or uncoupled (H^+^/e^−^ ratio of 0.0 ± 0.3), respectively.](pnas.2001572117fig04){#fig04}

Discussion {#s6}
==========

The mechanism by which mitochondrial C*c*Os, along with their bacterial homologs in the A1 branch of the HCO superfamily, maximize the energy conservation of the oxygen reduction reaction by translocating protons across the membrane remains a matter of debate ([@r14], [@r15], [@r17]). A key molecular aspect of this coupling mechanism is the identification of the paths within the protein structure that enable proton transfer, both from the N phase into the BNC for substrate protons and from the N phase into and out of a proton trap for the translocated protons. Three possible pathways---the D-, K-, and H-channels ([Fig. 1](#fig01){ref-type="fig"})---have been identified in the atomic structures of the central catalytic subunit I of both bacterial and mitochondrial C*c*Os ([@r7], [@r8]).

The ability to mutate the mtDNA-encoded subunit I of yeast C*c*O provides a means to further explore channel mutation effects and reconcile the body of data from C*c*Os of mammalian and bacterial origins ([*SI Appendix*, Table S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2001572117/-/DCSupplemental)). A range of random and site-directed mutations relevant to channel functions have been reported previously ([@r19], [@r21], [@r27][@r28][@r29]--[@r30]), several of which have been analyzed further here.

Inhibitory Mutations in the K-, D-, and H-Channels. {#s7}
---------------------------------------------------

Several mutations in bacterial oxidases have been shown to severely impair overall catalysis ([@r12], [@r31][@r32]--[@r33]). Mutation effects on specific component reactions have led to the conclusion that the K-channel conducts substrate protons into the BNC, but only during the two reductive steps before oxygen binds (the O→E→R steps) ([@r15], [@r34]) and/or may act as a "dielectric channel" to facilitate one or both of these steps ([@r35]). The D-channel provides the substrate proton route into the BNC for the remaining reductive steps (the P→F and F→O steps) after O-O bond cleavage ([@r14], [@r15], [@r36]).

In contrast, mutations within the bacterial H-channel (also referred to as the E-channel) did not generally have a marked effect on overall catalysis ([@r37]), with two exceptions. Mutation of conserved R52 to A or Q in *R. sphaeroides* ([@r31], [@r37]) did cause inhibition of catalysis but was linked to the disruption of its stabilizing interaction with the heme *a* formyl ([@r37]). Replacement of the equivalent residue in yeast with a methionine (R37M) was also linked to an assembly defect ([@r19]). Potentially more significant is a report of dramatically decreased catalytic activity in mutant H448L of *P. denitrificans* C*c*O, a residue located in the lower part of the H-channel (equivalent to H413 in bovine C*c*O; [*SI Appendix*, Table S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2001572117/-/DCSupplemental)). However, this loss appears to have arisen from a severe decrease in heme *a* incorporation rather than from an effect on coupled proton transfer ([@r31]). Furthermore, substitution of the equivalent H456 with a smaller alanine in *R. sphaeroides* C*c*O had no effect on TN or enzyme assembly ([@r37]).

*In S. cerevisiae*, D-channel mutants I67N and E243D and K-channel mutant T316K all resulted in longer doubling times of growth on respiratory substrate (\>10-, 4- to 5-, and \>10-fold, respectively). Consistent with this, their TNs in isolated mitochondria were 1%, 46%, and 15%, respectively. The inhibitory effects of T316K and E243D are consistent with observations in variants of the equivalent T359 of *R. sphaeroides* ([@r38], [@r39]), as well as with E/D replacement of the residue equivalent to E243 in *E. coli* ([@r40]), *P. denitrificans* ([@r31]), and *R. sphaeroides* ([@r41]). We previously showed that yeast mutant I67N ([@r42]), for which no equivalent bacterial mutant has been studied, is likely to interfere directly with E243 function at the top of the D-channel ([@r43], [@r44]) and to compromise substrate proton uptake ([@r45], [@r46]). These effects clearly confirm the expected essential roles of the D- and K-pathways in catalysis.

In contrast to these mutants, none of the yeast C*c*O H-channel mutants tested here significantly affected cell growth or catalytic TNs, consistent with behavior of both bacterial ([@r31], [@r37]) and bovine ([@r47], [@r48]) C*c*O H-channel mutations.

Uncoupling Mutations. {#s8}
---------------------

In all three bacterial A1-type HCOs, mutation of some specific asparagine and aspartic acid residues within the D-channel resulted in loss of coupled proton translocation associated with the remaining catalytic turnover. The first report of this was a D135N mutant of cytochrome *bo*~3~ ([@r40], [@r49]), which led to a complete loss of the proton pump accompanied with a decrease of TN to 45% of WT activity. A similar phenotype was reported for equivalent C*c*O variants D132N of *R. sphaeroides* ([@r38]) and D124N of *P. denitrificans* ([@r31]), although with a much more dramatic effect on their TNs (4% and 5% of WT activity, respectively). Slightly higher up in the D-channel, mutation N131D in *P. denitrificans* C*c*O had an ideal uncoupled phenotype ([@r50]) with complete loss of proton pumping while retaining close to 100% of the WT O~2~-reduction activity. The equivalent C*c*O variant N139D in *R. sphaeroides* also resulted in uncoupling of proton pumping, while having an increased catalytic activity of 150% to 300% of that of WT with unperturbed catalytic intermediates ([@r51]). Facing N131, mutation N199D of *P. denitrificans* C*c*O, and its N207D equivalent in *R. sphaeroides*, was also shown to uncouple the enzyme, with 45% of and close to WT activity, respectively ([@r50], [@r52]). Interestingly, double mutants of two of these loci (D132N/N139D in *R. sphaeroides*) restored full proton pumping capability ([@r53], [@r54]).

Despite these inconsistencies in effects among the three enzymes (and the fact that measurements were done in different ways on whole cells and purified enzyme reconstituted into vesicles and with pH-electrode vs. stopped-flow spectroscopy) ([@r31], [@r50], [@r55]), a consensus has been reached that these uncoupling effects arise from the dual role of the D-channel in providing the pathway for both translocated and substrate protons from the matrix (or cytoplasm), with *pK* changes caused by uncoupling mutations within the channel disrupting the necessary controlled distribution of protons between these pathways.

Equivalent D-channel mutations in a mitochondrial system have not been published previously. Instead, three uncoupling variants have been reported in a chimeric human/bovine system, all within the H-channel. These include the single variants D51N and S441P at the top of the H-channel and the double variant M390W/V386L in its lower part below heme *a* ([@r47], [@r48]). Normal electron transfer rates have been reported for all three variants, as would be expected for ideally uncoupled oxidases. These data, together with redox- and ligand-induced structural changes in two domains of the H-channel ([@r56][@r57][@r58]--[@r59]), have led to the proposal that it is the H-channel that provides the route for pumped protons both into and out of the proton trap. However, mutagenesis of H-channel residues of bacterial HCOs failed to support any crucial H-channel function. The sole bacterial H-channel mutation for which a loss of pump has been reported is H448L of *P. denitrificans* ([@r31]). As noted above, this phenotype has been called into question because of the associated dramatic TN inhibition (5% of WT) and severe defect of heme *a* assembly.

In terms of the effects of the yeast channel mutations on coupling efficiencies, D-channel mutant E243D, K-channel mutant T316K, or any of the H-channel mutants did not result in uncoupling of proton translocation from catalytic turnover. However, importantly and uniquely, of all the mutants tested, D-channel mutant N99D stimulated catalytic turnover (1.5-fold increase) while becoming uncoupled (H^+^/e^−^ stoichiometry of 0.2 ± 0.2) from proton translocation. This mutation also caused a moderate (1.5-fold) increase in cell doubling time, presumably resulting from the uncoupling effect. Mutation N99D in yeast is equivalent to the ideally uncoupled variants N131D of *P. denitrificans* and N139D of *R. sphaeroides* described above, demonstrating that the effect is common to both bacterial and mitochondrial enzymes. Thus, overall, the yeast mutant data clearly point to the same roles of the K- and D-channels in delivery of substrate and pumped protons as occur in homologous A1-type bacterial oxidases and argue against a role of the H-channel in channeling of protons from the N phase into the proton trap.

Given the similarity of structures in yeast and mammalian C*c*Os, it seems unlikely that the channel roles have evolved differently in mammalian C*c*Os. Nevertheless, some structural differences should be acknowledged. For example, in the lower section of the H-channel, a histidine residue is conserved in bovine (H413), *R. sphaeroides* (H456), and *P. denitrificans* (H448) C*c*Os; however, in yeast C*c*O, this is replaced by a glutamine (Q413). Mutation of this residue to leucine had no effect on respiratory growth competence, catalytic turnover, or coupling efficiency. In a parallel study ([@r60]), further mutations at this site also had negligible effects on respiratory growth competence or catalysis, and molecular dynamics simulations predicted that this span is incapable of protonic conductivity. Molecular dynamics simulations of the same region of bovine C*c*O also failed to support protonic conductivity of this span unless the histidine can form its imidazolium state, which is considered unlikely due to its low predicted *pK*~a~ value ([@r61]).

Although the D-channel route into the proton trap is most likely as described above, the path from the trap into the P phase remains generally unresolved. The likely proton trap region is "above" the BNC and close to the bound Mg^2+^/Mn^2+^ site ([@r16], [@r62]). Protonic connectivity between the trap and P phase may be made through the relatively hydrated "top" region of the H-channel, possibly linked via the conserved pair of arginine ligands to the heme *a* propionates. Several specific routes have been suggested from structures or simulations of bacterial ([@r63], [@r64]) and bovine ([@r16], [@r65]) C*c*Os. Although some amino acids in this region are not well conserved among mammalian, yeast, and bacterial C*c*Os ([*SI Appendix*, Table S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2001572117/-/DCSupplemental)), the hydrated domains are structurally similar and extensive. Thus, for all C*c*Os, this top region of the H-channel may provide a hydrated H-bonded network with several facile proton pathways into the P phase.

Yeast Mutants D445E and E39Q Do Not Affect Proton Coupling. {#s9}
-----------------------------------------------------------

Apart from the K- and D-channel variants described above, only mutation of D445E was found to impair catalytic TN (44% of WT), again with direct repercussion on respiratory growth competence with a cell doubling time greater than fourfold longer than that of WT. D445 is at the top of helix XI, in a region above the proposed calcium-binding site at the interface of Cox1, Cox5a, and Cox2 ([@r18]) and within H-bonding distance of T123 and M124 of Cox5a and the main chain amide of R159 of Cox2. From Fourier-transform infrared spectroscopy studies, R159 has been implicated in Ca^2+^/Na^+^ binding via the salt bridge formed by its guanidinium with D442 of Cox1 ([@r66]). Replacement of D445 with the longer side chain glutamic acid most likely disrupts these interactions. Such disruption could impact biogenesis, which starts with the assembly of a Cox1-Cox5 module before association with Cox2 ([@r67]). Indeed, the low level of observable heme *a* in this variant is ∼20% that in WT cells (at 0.4 nmol C*c*O/g wet weight of cells and a correspondingly low heme *a*/*bc*~1~ complex ratio in mitochondria), which could be caused by an assembly defect or possibly poor heme *a* incorporation. Misfolding of this region could also alter the presentation of residues at the surface, with effects on cytochrome *c* docking and electron transfer to the dinuclear Cu~A~ center.

In contrast, mutation E39Q, a residue directly involved in calcium binding, had no effect on TN or cell growth, consistent with studies on the equivalent bacterial variant ([@r68]). Importantly, neither D445E nor E39Q had an effect on the extent of coupled proton transfer. Thus, despite being potentially linked into the extensive hydrated top region of the H-channel, neither residue can have an essential function in the proton exit route from the trap into the P phase.

In summary, whether the H-channel can play a role in modulating catalysis or whether its top domain can provide an exit route for protons from trap into the P phase remains to be investigated. The present work has definitely established that, as for equivalent bacterial systems, the D-channel is the lower part of the pumping element for proton translocation in yeast mitochondrial C*c*O.

Materials and Methods {#s10}
=====================

Yeast extract was purchased from Ohly. All chemicals were purchased from Sigma-Aldrich unless specified otherwise.

Construction of Yeast Mutants. {#s11}
------------------------------

Of the 12 mutants studied, three (I67N, T316K, and D445E) were obtained by random mutagenesis as first described by Meunier et al. ([@r27]) and the other nine were constructed by site-directed mutagenesis following a previously described method ([@r69], [@r70]). The mutations were transferred by cytoduction ([@r71]) into a strain derived from W303-1B ([@r72]) that carries a 6-histidine tag sequence on the 3′ end of nuclear gene *COX13* ([@r19]). 6H-WT and all mutants have identical nuclear and mitochondrial genomes, except for the point mutations in *COX1*. Strains WT and 6H-WT differ only by the 6-histidine tag on COX13.

Yeast Culture on Respiratory Medium. {#s12}
------------------------------------

Yeast cells were grown at 28 °C in respiratory YPGly medium (1% yeast extract, 2% peptone, 2% glycerol) in two parallel flasks, with the second flask inoculated 8 h after the first flask. Every 2 h a sample was taken in each flask under aseptic conditions, and the OD~600~ value was measured, interpolating sampling times of the second flask to best cover the complete time range of growth. The doubling time for each strain was derived from a fit to the linear region of log~10~-vs.-time plots using OriginPro (OriginLab), and the error displayed is the SE of the fit.

Catalytic TNs. {#s13}
--------------

TNs for each mutant strain were determined in mitochondrial membrane fragments prepared from cells cultured in YPGal medium (1% yeast extract, 2% peptone, 2% galactose), as described by Meunier et al. ([@r19]), by measurement of steady-state oxygen consumption rates at 25 °C with a Clark-type oxygen electrode (Oxygraph; Hansatech). Assays were conducted in a medium of 10 mM KPi and 50 mM KCl at pH 6.6 and containing 0.05% n-dodecyl-β-D-maltoside, 40 μM TMPD, and 50 μM horse heart cytochrome *c*. After equilibration and recording of the basal rate, the reaction was initiated by the addition of 2 mM Na^+^-ascorbate. TNs were calculated as e.s^−1^.C*c*O^−1^ from a fit to the linear region of the oxygen consumption rate using Origin (OriginLab). Results are the average (± SD) of *n* independent experiments from at least two independent mitochondrial preparations.

Preparation of Intact Mitochondria. {#s14}
-----------------------------------

Intact mitochondria were prepared from 12 to 15 g of yeast cells (wet weight) grown aerobically at 28 °C in YPGal medium (1% yeast extract, 2% peptone, 2% galactose) and harvested in log phase. The digestion of the yeast cell wall was performed enzymatically following a modified version of the protocol described by Guérin et al. ([@r73]). First, cells were incubated for 10 min at 32 °C with 20 mL per g of wet weight of cells of a solution containing 0.1 M Tris⋅HCl and 0.5 M β-mercaptoethanol at pH 9.3. Cells were then pelleted for 5 min at 2,500 × *g* and 4 °C, after which the supernatant was discarded. The cell pellet was washed twice by resuspension/centrifugation (5 min at 2,500 × *g*) cycles performed at 4 °C with 500 mL of 10 mM Tris⋅HCl and 0.5 M KCl at pH 7. The final pellet of cells was resuspended in a solution containing 1.35 M sorbitol, 1 mM EGTA, 10 mM citric acid, and 30 mM sodium phosphate at pH 5.8 at a volume of 10 mL per g of wet weight of cells. Zymolyase (MP Biomedicals) was added to the cell suspension at a concentration of 10 mg per g of wet weight of cells, and the mixture was incubated in a water bath at 32 °C, with occasional mixing, for 60 to 90 min. Spheroplast formation was followed by visual inspection under a light microscope of aliquots of the cell suspension diluted by a factor of 2 with water. Once digestion was complete, the spheroplast suspension was centrifuged for 5 min at 4,000 × *g* and 4 °C, and the supernatant was removed. The spheroplast pellet was washed twice by resuspension/centrifugation (5 min at 2,500 × *g*, 4 °C) cycles performed at 4 °C with 200 mL of a solution containing 0.75 M sorbitol, 0.4 M mannitol, 0.1% BSA (w:v), and 10 mM Tris-maleate at pH 6.8. The resulting pellet was resuspended with a solution of 0.5 M mannitol, 0.2% BSA (w:v), 2 mM EGTA, and 10 mM Tris-maleate at pH 6.8 and then transferred to a Potter--Elvehjem homogenizer with a Teflon pestle, where spheroplast lysis was achieved both osmotically and mechanically. The suspension was centrifuged for 10 min at 800 × *g* and 4 °C, and the pellet was discarded. The supernatant was distributed among six centrifuge tubes and centrifuged for 10 min at 12,000 × *g* and 4 °C. The resulting mitochondrial pellets were resuspended in a small volume of solution containing 0.6 M mannitol, 2 mM EGTA, and 10 mM Tris-maleate at pH 6.8 (buffer A) and gently homogenized with the Potter pestle, and the centrifuged tubes were refilled again with buffer A. Following a low-speed centrifugation (5 min at 800 × *g* and 4 °C) with elimination of the resulting pellets, the supernatants were centrifuged for 10 min at 12,000 × *g* and 4 °C. The pellets obtained were washed once more with buffer A, following the above steps of homogenization, low-speed centrifugation, and high-speed centrifugation. The final pellet of mitochondria was resuspended with the smallest amount of buffer A and gently homogenized with a small Potter--Elvehjem homogenizer, and ADP/O ratios were measured immediately.

ADP/O Ratio Measurements. {#s15}
-------------------------

ADP/O measurements were performed with the oxygen-electrode setup described above in a medium of 0.65 M mannitol, 5 mM MgCl~2~, 3 mM KPi, 10 mM Tris-maleate, 17 mM KCl, and 0.1% BSA (w:v) at pH 7.0 and 25 °C. Oxygen consumption rates were determined after successive additions of intact mitochondria (10 to 20 μL), 10 mM α-ketoglutarate (Na^+^ salt), and 100 μM ADP (Na^+^ salt). The latter induced state 3 of respiration, which spontaneously reverted to state 4 after all the ADP was transformed into ATP. The RCR was calculated from the ratio of the state 3 to state 4 oxygen consumption rates measured. The ADP/O values presented here are the average of the ADP/O~T~ and ADP/ΔO values determined after ADP addition; error bars represent the SD from the mean. O~T~, representing the total oxygen consumed during state 3 assuming no state 4 in state 3, was determined graphically from the difference in oxygen concentrations between the onset of state 3 and the intersection of the two straight lines extrapolating state 3 and state 4. ΔO represents the oxygen consumed during state 3 assuming that state 4 occurs also in state 3. ΔO was determined graphically from the difference in oxygen concentration between the two straight lines extrapolated from the linear regimes of oxygen consumption before ADP addition and after stabilization of state 4, measured at the point at which one-half of the O~T~ had been consumed.

Data Availability. {#s16}
------------------

All relevant data are included in the paper and are available from the corresponding author upon reasonable request.
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